X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (419) 419
Publication (14) 14
Book / eBook (12) 12
Book Review (6) 6
Newspaper Article (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (284) 284
cardiac & cardiovascular systems (194) 194
male (173) 173
female (172) 172
middle aged (154) 154
aged (125) 125
index medicus (70) 70
angioplasty (57) 57
heart attack (57) 57
cardiology and cardiovascular medicine (56) 56
mortality (55) 55
risk factors (55) 55
angioplasty, balloon, coronary (53) 53
myocardial infarction - drug therapy (50) 50
recurrence (49) 49
treatment outcome (48) 48
thrombolytic therapy (47) 47
prognosis (45) 45
coronary disease - therapy (44) 44
myocardial infarction - therapy (44) 44
acute myocardial-infarction (43) 43
adult (43) 43
time factors (43) 43
follow-up studies (42) 42
cardiac patients (41) 41
cardiology (41) 41
cardiovascular (41) 41
drug therapy (41) 41
myocardial infarction - mortality (41) 41
heart attacks (40) 40
analysis (39) 39
platelet aggregation inhibitors - therapeutic use (39) 39
therapy (39) 39
cardiovascular disease (38) 38
coronary angiography (38) 38
coronary heart disease (36) 36
prospective studies (35) 35
myocardial-infarction (34) 34
aspirin (33) 33
cardiovascular system (32) 32
transluminal angioplasty (32) 32
coronary artery bypass (31) 31
health aspects (31) 31
tissue plasminogen activator - therapeutic use (31) 31
tissue plasminogen-activator (31) 31
electrocardiography (30) 30
risk (30) 30
ticlopidine - analogs & derivatives (30) 30
care and treatment (29) 29
complications (29) 29
disease (29) 29
abridged index medicus (28) 28
angioplasty, balloon (28) 28
coronary vessels (28) 28
randomized trial (28) 28
unstable angina (27) 27
research (26) 26
drug therapy, combination (25) 25
fibrinolytic agents - therapeutic use (25) 25
randomized controlled trials as topic (25) 25
streptokinase (25) 25
animals (24) 24
clinical trials as topic (24) 24
acute coronary syndromes (23) 23
clinical trials (23) 23
internal medicine (23) 23
myocardial infarction (23) 23
myocardial infarction - physiopathology (23) 23
ticlopidine - therapeutic use (23) 23
medicine, general & internal (22) 22
double-blind method (21) 21
stroke (21) 21
heart (20) 20
incidence (20) 20
prevention (20) 20
risk assessment (20) 20
studies (20) 20
trial (20) 20
usage (20) 20
angioplasty, balloon, coronary - adverse effects (19) 19
hemorrhage - chemically induced (19) 19
heparin (19) 19
medicine (19) 19
retrospective studies (19) 19
aged, 80 and over (18) 18
clopidogrel (18) 18
evaluation (18) 18
genetics & heredity (18) 18
reperfusion (18) 18
united states (18) 18
aspirin - therapeutic use (17) 17
genetic aspects (17) 17
heparin - therapeutic use (17) 17
platelet aggregation inhibitors - adverse effects (17) 17
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (17) 17
survival analysis (17) 17
coronary arteries (16) 16
coronary disease - mortality (16) 16
recombinant proteins - therapeutic use (16) 16
stents (16) 16
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 49, Issue 19, pp. 1982 - 1988
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 5, pp. 818 - 824.e1
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 4, pp. 291 - 295
Lack of Evidence of a Clopidogrel-Statin Interaction in the CHARISMA Trial Jacqueline Saw, Danielle M. Brennan, Steven R. Steinhubl, Deepak L. Bhatt, Koon-Hou... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATELET INHIBITION | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Heptanoic Acids - metabolism | Prospective Studies | Follow-Up Studies | Cytochrome P-450 CYP3A | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Cytochrome P-450 Enzyme System - metabolism | Male | Heptanoic Acids - adverse effects | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Pyrroles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Heptanoic Acids - administration & dosage | Pravastatin - adverse effects | Pyrroles - adverse effects | Ticlopidine - administration & dosage | Female | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Pyrroles - metabolism | Cardiovascular Diseases - metabolism | Double-Blind Method | Pravastatin - metabolism | Ticlopidine - analogs & derivatives | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Pravastatin - administration & dosage | Atorvastatin | Clopidogrel | Hemorrhage - chemically induced | Analysis | Cytochrome P-450 | Studies | Confidence intervals | Body mass index | Stroke | Heart attacks | Heart surgery | Coronary vessels | Drug therapy | Acute coronary syndromes | Drug dosages | Statins | Veins & arteries
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 13, pp. 1489 - 1496
Abstract So far, the digitization of health care is best exemplified by electronic medical records, which have been far from favorably or uniformly accepted.... 
Cardiovascular | Internal Medicine | electronic health records | technology | patient care | physician-patient relations | artificial intelligence | health care | Physician and patient | Health care reform | Sensors | Digitization | Heart attacks | Physicians | Weather forecasting
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2009, Volume 2, Issue 10, pp. 917 - 924
Objectives We hypothesized that patients most likely to benefit would be those at high risk with a shorter duration of acute ischemia and who required transfer... 
Cardiovascular | percutaneous coronary intervention | STEMI facilitation | TRIALS | RETEPLASE | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | SCORE | NATIONAL-REGISTRY | REPERFUSION | ABCIXIMAB | PRIMARY ANGIOPLASTY | Recombinant Proteins - therapeutic use | Myocardial Infarction - mortality | Humans | Immunoglobulin Fab Fragments - adverse effects | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Recombinant Proteins - adverse effects | Tissue Plasminogen Activator - adverse effects | Angioplasty, Balloon, Coronary - adverse effects | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Multicenter Studies as Topic | Angioplasty, Balloon, Coronary - mortality | Time Factors | Health Services Accessibility | Fibrinolytic Agents - therapeutic use | Retrospective Studies | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | Thrombolytic Therapy - mortality | Randomized Controlled Trials as Topic | Hemorrhage - chemically induced | Thrombolytic Therapy - adverse effects | Patient Transfer | Index Medicus
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 175, pp. 77 - 85
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2007, Volume 120, Issue 3, pp. e5 - e5
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 7, pp. 669.e1 - 669.e7
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2009, Volume 103, Issue 10, pp. 1359 - 1363
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 157, Issue 4, pp. 658 - 665
Journal Article